rfi.ac.uk的 10 大竞争对手

rosalindfranklin.edu

As RFU faculty, staff, and administrators, you help shape the future of health care by preparing tomorrow’s leaders for the challenges of their profession. You

ses.ai

SES AI specializes in developing and manufacturing high-performance lithium-metal rechargeable batteries for electric vehicles and various other applications.

ptcbio.com

For Sam, publishing his first book was nerve-wracking – it chronicled his Friedreich’s ataxia (FA) diagnosis and was therefore very personal. He wasn’t sure what people would think, but he was pleased with the positive reception of his book. Sam is a passionate writer and has since published five more books. In this video, Sam…

zealandpharma.com

Zealand Pharma is a biotechnology company dedicated to developing innovative peptide-based medicines for people living with unmet medical needs

leibniz-fmp.de

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the Faculty of Medicine at Kiel University, and the Leibniz Institute of Virology in Hamburg are jointly receiving funding of nearly one million euros as part of the "Leibniz Cooperative Excellence" program. The goal of the project is to unravel fundamental mechanisms of two-pore domain potassium channels (K2P channels) – with potential new therapeutic approaches for cancer, autoimmune diseases, infectious diseases, central nervous system disorders, and cardiovascular diseases.

nottinghambrc.nihr.ac.uk

the nottingham biomedical research centre (brc) is improving the health of millions of people with common diseases like asthma, depression and arthritis.

cimus.usc.gal

the center for research in molecular medicine and chronic diseases (cimus) is a member of the singular research centers network, a core structure of the campus of international excellence– campus vida project, university of santiago de compostela.

omrf.org

Trivia night fundraiser served as group's capstone event

hansabiopharma.com

We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.

innoprot.com

Numerous studies have been published about the implication of the neurotrophin brain-derived neurotrophic factor (BDNF) and its receptor TrkB in the pathogenesis of several neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis and motor neuron disease. BDNF activates the TrkB receptor with high potency and specificity, promoting neuronal survival, differentiation and synaptic plasticity. […]